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ABSTRACT 
Oxidative stress is described as an imbalance between oxidants and antioxidants, with a shift 
towards the oxidants. When the antioxidative systems are insufficient or the production of 
radicals is increased oxidative damage can occur, damaging DNA, lipids, and proteins. 
Oxidative stress has been implicated in several pathologies. This study has been focused on 
oxidative damage caused to the cysteine residues on proteins. The main function of the 
thioredoxin (Trx) and the glutaredoxin (Grx) systems is to reduce protein thiols and they 
therefore play an important role in the protection against oxidative stress.  
Alzheimer’s disease is a progressive disease with a high prevalence in an aging population. 
Oxidative stress has been implicated in the disease, as demonstrated by elevated levels of 
oxidized proteins, lipids, carbohydrates and nucleic acids. In our study we were able to show 
that Trx and Grx were secreted to CSF, and that the levels of the proteins correlated with the 
previously validated markers tau and p-tau in patients with different stages of AD. The 
secretion was not caused by cell death as the levels of lactate dehydrogenase did not change 
between the different stages. Furthermore, decreased axonal staining of Grx1 and Grx2, as 
well as decreased mitochondrial staining of Trx2 was observed in AD hippocampus.  
Parkinson’s disease (PD) is characterized by loss of dopaminergic neurons in the substantia 
nigra. The neurotransmitter dopamine has been implicated in the pathology, as rupture of the 
dopamine vesicles leads to increased cytosolic dopamine levels. Free in the cytosol, 
dopamine gets oxidized with a release of radicals in the process. We can show a direct 
interaction between the Trx system and the dopamine-quinone. Furthermore, a protective 
effect of TrxR against dopamine toxicity was observed in both the cell line SH-SY5Y and in 
the nematode C. elegans. In addition, decreased levels of Trx1 and TrxR1 were observed in 
substantia nigra from PD patients.  
Ischemia causes a conversion of xanthine dehydrogenase into xanthine oxidase, upon 
reperfusion xanthine oxidase releases radicals, leading to an increased oxidative stress in the 
tissues. Ischemia/reperfusion was induced in human livers, and samples were taken before 
induction of ischemia, after ischemia and after reperfusion. We demonstrated that the major 
reperfusion damage was to the sinusoidal endothelial lining, where a retraction of the lining 
occurred after ischemia, but after 20 minutes of reperfusion the cell lining had partially 
recovered. No significant changes in mRNA levels of redox proteins could be observed, but 
likely redistribution of Trx occurred in the hepatocytes. 
Cell lines are commonly used in medical research, but a consensus in how to culture the cells 
is lacking. In order to study the effect of media selection, three different cell lines were 
cultured in four commonly used cell culturing media. We could observe increased 
proliferation of cells grown in the high glucose containing DMEM. Increased expression for 
mesenchymal marker Vimentin in A549 cells cultured in DMEM, and decreased expression 
of epithelial marker CK18, which indicates a possible change in phenotype due to the 
selection of media. Furthermore, increased enzymatic activity of TrxR in cells cultured in 
MEM compared to the other media was observed, and decreased selenite toxicity in cells 
cultured in DMEM compared to culture in RPMI or F12. This study highlights the 
importance of consistency in the choice of cell culturing media for the outcome of any cell 
experiment.  
In conclusion, the thioredoxin family of proteins has been shown to be implicated in several 
pathological conditions where oxidative stress is believed to be important.  
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1 INTRODUCTION 
1.1 POPULÄRVETENSKAPLIG SAMMANFATTNING 
I litteraturen beskrivs oxidativ stress som ”En obalans mellan oxidanter och antioxidanter, 
med fördel för oxidanterna, vilket leder till störningar i redox signalering och kontroll 
och/eller molekylära skador”. 
Varje cell i kroppen innehåller flera så kallade organeller, de största och viktigaste är kärnan, 
endoplamiska reticulumet (ER), och mitokondrien. Dessa har alla sina specifika uppgifter, i 
kärnan finns DNA vars kod läses av för att med hjälp av ER producera proteiner. Proteiner 
(tidigare kallade äggviteämnen) är funktionella molekyler som utför uppgifter åt cellerna. 
Mitokondrien är ansvarig för energiproduktionen och där omvandlas socker och syre till 
energiformen ATP. Den energi som bildas i mitokondrien används för att driva 
energikrävande processer i cellen.  
I mitokondriens energiproduktion sker normalt ett läckage av elektroner på ca 1-2% av de 
elektroner som används för energiproduktionen. Dessa bidrar till bildandet av fria radikaler. 
En fri radikal är en extremt reaktiv molekyl som kan orsaka skada på de omkringliggande 
molekylerna. Som skydd mot fria radikaler använder sig cellen av så kallade antioxidanter, 
vissa tas upp ur födan och andra produceras av cellen själv.   
I de fall när antingen mängden antioxidanter är för liten eller produktionen av fria radikaler är 
för stor uppstår en oxidativ stress i cellen. Fria radikaler kan orsaka skador på alla de 
väsentliga komponenterna i cellen, så som DNA, fetter och proteiner etc. I den här 
avhandligen undersöks de skador som uppstår i proteiner utav fria syre radikaler. Svavel är en 
väsentlig del i många proteiner, då den ofta är en del av den reaktiva mekanismen hos 
proteinet.  Arbetena inkluderade i den här avhandlingen är fokuserade på två av dessa system, 
thioredoxin (Trx) och glutaredoxin (Grx) systemen. Dessa har som huvuduppgift att bryta de 
svavel-svavel bindningar som bildas i proteiner då de utsätts för oxidativ stress och därmed 
återställa deras funktion.  
Mitokondriella förändringar har upptäckts i flera sjukdomar och i dessa fall så ökar läckaget 
av elektroner, varpå den oxidativa stressen ökar. Oxidativa förändringar har setts vid 
neurodegenerativa sjukdomar såsom Parkinsons sjukdom och Alzheimers sjukdom.  
I det första arbetet har nivåerna av Trx och Grx bestämts i blodet och ryggmärgsvätskan från 
patienter med varierande grad av Alzheimers sjukdom. Vi kunde se att nivåerna av 
framförallt Trx korrelerade med andra, tidigare validerade, diagnostiska markörer. Vi föreslår 
att Trx bör mätas på patienter med misstänkt Alzheimer för att kunna diagnostisera 
sjukdomen i ett tidigare skede.  
I det andra arbetet har vi studerat Trx och Grx roll i Parkinsons sjukdom. Vid Parkinsons 
sjukdom dör framförallt de nervceller som använder sig utav, och producerar, 
signalsubstansen dopamin. Normalt sett förvaras dopamin i små blåsor i cellen. Vid ökad 
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oxidativ stress går dessa blåsor sönder och dopamin läcker ut i cellen. Dopamin är extremt 
känsligt för oxidation och när det kommer i kontakt med syre förändras dess kemiska struktur 
och fria radikaler bildas. Vi har studerat Trx och Grx roll vid den cell död som orsakas av 
dopamin. Vi kan visa att då celler i odling behandlas med dopamin så skyddar Trx mot den 
toxiska effekten av dopamin. Vi kan även visa att patienter med Parkinsons sjukdom har 
minskade nivåer av Trx i de dopaminproducerande cellerna.  
Ischemi är det tillstånd som uppstår då blodflödet temporärt stoppas till en vävnad. När 
blodflödet släpps på igen och syre strömmar in i vävnaden så uppstår en massiv oxidativ 
stress. I det tredje arbetet har vi studerat vad som händer med levern efter att den utsatts för 
ischemi. Vi har även studerat hur Trx kan vara involverat i denna process. Vi kunde visa att 
Trx nivåerna varierade mellan patienterna och att Trx troligen släpps ut från cellerna efter att 
blodflödet är återställt. 
I det fjärde arbetet, som är ett metodarbete, har vi studerat hur olika cellodlingsmedium 
påverkar cellernas utseende, hur de klarar att hantera olika toxiska föreningar, samt hur 
nivåerna av Trx och Grx påverkas av att cellerna odlats i olika medium. Vi kan visa att val av 
cellodlings medium är av stor betydelse för att kunna jämföra data från olika studier.  
Sammanfattningsvis så har vi har visat att Trx är involverat i flera olika sjukdomstillstånd där 
oxidativ stress tros vara en av de bakomliggande orsakerna.  
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1.2 OXIDATIVE STRESS 
The field of oxidative stress has grown in recent years but the definition of oxidative stress is 
not always clear. Oxidative stress has, in a recent review on the concept of oxidative stress, 
been defined as follows: “An imbalance between oxidants and antioxidants in favor of the 
oxidants, leading to a disruption of redox signaling and control and/or molecular damage” 
[1]. 
This study is focused on the role of thiol regulating protein systems during conditions of 
oxidative stress.  
1.2.1 The complexity of redox regulation 
Human diet contains antioxidants and prooxidants in varying proportions [2]. The beneficial 
effects of foods and drinks containing antioxidants have been extensively studied in the last 
years. For example, the risk of coronary heart infarction was shown to decrease in a dose 
dependent manner when the total antioxidant capacity of the diet increases [3]. Wine grape 
pomace flour was shown to improve blood pressure, fasting glucose and protein damage in a 
controlled study in human subjects [4]. Furthermore, in a study on primary human 
keratinocytes the antioxidant caffeine was shown to have wound healing effects [5], and in a 
human study on healthy males, dark roast coffee was shown to decrease the level of 
spontaneous DNA strand breaks [6]. Coffee was also shown to have a high peroxyl radical 
scavenging activity [7]. In contrast, in a study on coffee, tea, and cocoa, micromolar 
concentrations of H2O2 could be detected in coffee [8]. In addition, increased levels of H2O2 
could be detected in the urine of healthy volunteers after drinking coffee [9]. This controversy 
highlights the fact that not all antioxidants are good, and not all oxidants are bad.  
1.2.1.1 Oxidative stress produced by external stimuli 
Throughout life we are subjected to several risks for an increased oxidative stress. Exogenous 
reactive oxygen species (ROS) production is derived from pollutants [10], tobacco smoke 
[11], iron salts, and UV [12] and ionizing radiation [13] etc. Furthermore, dependent on the 
dose, several dietary components has the ability to induce an increased production of reactive 
species. In addition, aerobic metabolism is constantly exposing the body to oxidizing insults 
where every breath increases the risk for oxidative modifications. 
1.2.2 Cellular sources of ROS 
The cellular sources of ROS during stressful and nonstressful conditions depend on the tissue 
type and the subcellular components. Usually mitochondria, the endoplasmic reticulum (ER) 
and peroxisomes are described as the main producers of cellular ROS, the levels produced by 
each organelle vary depending on the tissue and situation (Figure 1). 
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Figure 1. Formation and removal of radicals. The first line of defense against oxygen 
radicals formed by redox processes in the cell. ER; Endoplasmic reticulum, SOD; Superoxide 
dismutase, Prx; Peroxyredoxin, CAT; Catalase, GPx; Glutathione peroxidase. 
 
1.2.2.1 Mitochondria 
Oxygen is vital for all aerobic organisms in order to produce sufficient amounts of energy in 
the form of adenosine triphosphate (ATP) [14]. Molecular oxygen is used as an electron 
donor in the mitochondrial electron transport chain (ETC). In the Krebs cycle the reducing 
equivalents Nicotinamide adenine dinucleotide (NADH) and Flavin adenine dinucleotide 
(FADH2) are formed. NADH + H+ are used in complex I of the ETC, where it is oxidized to 
NAD. Furthermore, complex II is reducing FAD to FADH2. The electrons released from 
reactions in complex I and II are then transferred, via a series of prosthetic Fe-S groups, to 
ubiquinone which is reduced by complex III, producing ubiquinol. In complex IV, the 
electrons from ubiquinol are used to reduce O2, forming H2O. Furthermore, during these 
processes, protons are pumped out into the intermembrane space of the mitochondria. The 
proton gradient created during the processes is used to drive the ATP production in complex 
V (The function of the ETC has been described in detail in [15]). During normal 
physiological conditions ~2% of the oxygen intake to the mitochondria is converted to 
superoxide radicals [16]. A leak of electrons can occur at several sites in the ETC, but the 
major physiological and pathological production of superoxide is at the Flavin 
mononucleotide (FMN) group in complex I [17]. The complexes of the electron transport 
chain is however not the only site in the mitochondria where ROS is produced [15]. ROS 
production from 2-oxoglutarate dehydrogenase (OGDH), Branched chain 2-oxoacid 
dehydrogenase (BCKDH), and Pyruvate dehydrogenase (PDH) have also been observed, and 
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depending on the substrates present, the dominant sites of superoxide/hydrogen peroxide 
production may be the OGDH and PDH complexes in the mitochondria, which previously 
could have been misattributed to complex I [18]. 
1.2.2.2 Endoplasmic reticulum 
The endoplasmic reticulum (ER) is responsible for oxidative protein folding, and is rich in 
oxygenases and oxidases (e.g., cytochrome P450s, flavin-containing monooxygenases, prolyl 
and lysyl hydroxylases), which often produce ROS as a byproduct. For example, about one 
fourth of the ROS produced in a professional secretory cell comes from the oxidative protein 
folding in the ER [19].  
1.2.2.3 Peroxisome 
The primary function of the peroxisome is to participate in the cellular lipid metabolism and 
many peroxisomal enzymes catalyze redox reactions as part of their normal function. 
Peroxisomes also play a central role in the cellular metabolism of hydrogen peroxide, 
illustrated by the fact that these organelles harbor large amounts of enzymes that can produce 
the molecule. Peroxisomes also contain enzymes that generate superoxide (e.g. xanthine 
oxidase) as part of their normal catalytic activity, giving these organelles the potential to act 
as a source of radicals [20]. 
1.2.3 The benefits of radical formation 
Normal metabolism yields free radicals which are used in cellular processes. At moderate or 
low levels ROS have beneficial effects and are involved in various physiological reactions. 
For example, free radicals are vital in the defense against pathogens. In phagocytes, such as 
macrophages and neutrophils, the plasma membrane contains nicotinamide adenine 
dinucleotide phosphate (NADPH)-oxidase which reduces O2 into superoxide (O2●-), a 
mechanism called “oxidative burst” [21]. O2●- is relatively inactive towards microbial 
pathogens, and is therefore converted into hydrogen peroxide by superoxide dismutase (SOD) 
present in the pathogens ingested by the phagocyte, releasing the more reactive hydrogen 
peroxide [22]. In addition, signal transduction with the radical nitric oxide (NO●) is involved 
in a number of important physiological processes, such as synaptic plasticity, neuronal 
survival, vasodilation, vascular homeostasis, immune regulation [23]. During smooth muscle 
relaxation, NO● is used as a signaling molecule in order to control the blood pressure in the 
body. NO● is also involved in neuronal signaling but is, unlike other neurotransmitters, not 
stored in vesicles but instead produced when needed by nitric oxide synthase (NOS) [24]. 
Synthesis of NO● is stimulated during transmission by a Ca2+-dependent mechanism. Once 
NO● has been synthesized, it can diffuse freely through membranes to the post junctional 
targets [25]. 
1.2.4 Reactive oxygen, free radicals and antioxidants 
A free radical is an atom or a molecule with one or more unpaired electrons, for example 
superoxide anion radical (O2●-), hydroxyl radical (●OH), nitric oxide (●NO), or lipidperoxyl 
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radical (LOO●) [14]. The odd number of electron(s) of a free radical makes it unstable, short 
lived and highly reactive. Radicals will donate their unpaired electron to other molecules 
forming other types of radical species. 
1.2.4.1 Superoxide (O2●-) 
The superoxide anion is the most widespread radical and is formed when an electron is 
transferred to molecular oxygen. The two unpaired electrons present in the outermost orbital 
of molecular oxygen can only accept one electron at a time when it is being reduced [26]. 
Superoxide is mainly produced in the mitochondria and can be formed by autooxidation and 
by nonenzymatic reactions where an electron is transferred to molecular oxygen. 
Furthermore, there are several enzymes that can produce superoxide, for example xanthine 
oxidase, lipoxygenase, cyclooxygenase, and NADPH dependent oxidase [27].  
1.2.4.2 Superoxide dismutase 
Dismutation of superoxide occurs enzymatically through superoxide dismutase, where 
superoxide is converted into hydrogen peroxide and molecular oxygen. There are three 
known isoforms of superoxide dismutase (SOD); SOD1 (CuZn–SOD) present in the cytosol, 
nucleus, and mitochondrial inner membrane, SOD2 (Mn–SOD) in the mitochondrial matrix, 
and SOD3 (Ni–SOD) extracellularly [28]. The dismutation by SOD keeps the concentration 
of superoxide in the low picomolar range [29].  
1.2.4.3 Scavenging of hydrogen peroxide 
Hydrogen peroxide reacts poorly or not at all with most biological molecules and low 
molecular weight antioxidants, reaction does however occur with selected biological targets 
with transition metal centers, selenoproteins, and a small selection of thiol proteins [30]. 
Hydrogen peroxide can be scavenged by three enzymatic systems; peroxiredoxin (Prx), 
catalase (CAT), and glutathione peroxidase (GPx), of which the most efficient is the Prx 
system.  
Peroxiredoxins exist as dimers, with two critical cysteine residues per monomer; the 
peroxidatic cysteine and the resolving cysteine [31, 32]. Upon interaction with hydrogen 
peroxide, the peroxidatic cysteine is oxidized to a sulfenic acid, which generates an 
intermolecular disulfide with the resolving cysteine of the other monomer to release water. 
As neither SOD nor catalase has been found in ER, the Prx system is vital for dismutation of 
radicals in this organelle [19]. The kinetics behind the decomposition of hydrogen peroxide 
by catalase was first described in 1924 [33]. Catalase is primarily an intracellular enzyme; its 
highest concentrations in mammals are found in peroxisomes in erythrocytes and liver [34]. 
Glutathione peroxidase catalyzes the reduction of hydrogen peroxide concomitant with the 
oxidation of two molecules of glutathione (GSH) [35].  
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1.2.4.4 Hydroxyl radical (●OH) 
Cleavage of the oxygen-oxygen bond in hydrogen peroxide (H2O2) leads to the formation of 
the highly reactive hydroxyl radical. The hydroxyl radical can be formed either by cleavage 
of H2O2 by UV irradiation [14], or in the presence of iron (or copper) according to the Fenton 
reaction (reviewed in [36]): 
Fe2+ + H2O2  Fe3+ + ●OH + OH- (A) 
Fe3+ + H2O2  Fe2+ + ●OOH + H+ (B) 
In reaction (A) one electron is donated from Fe2+ to hydrogen peroxide, which forms the 
hydroxyl radical and hydroxide ion (OH-). The oxidized iron (Fe3+) participates in reaction 
(B), where hydrogen peroxide is cleaved, forming the simplest form of peroxyl radical 
(ROO●); perhydroxyl radical (●OOH). Hydrogen peroxide has a half-life of milliseconds, is 
membrane permeable, and has a steady state concentration in the cell in the nanomolar to low 
micromolar range [29].  
1.2.4.5 Antioxidants 
In addition to enzymatic scavenging of radicals, there are several low molecular weight 
antioxidants present in the cell. The antioxidant effects in vivo are dependent on the 
bioavailability of antioxidants as determined by uptake, distribution, metabolism, and 
excretion. These low molecular weight antioxidants possess redox-active properties, and are 
capable of quenching radicals or diminish the oxidation of other molecules, playing a key role 
in cellular defense. Some antioxidants are ingested in the diet. For example, ascorbate 
(vitamin C), tocopherols (e.g., vitamin E), and napthoquinoids (e.g., vitamin K), are 
antioxidants that are not synthesized de novo in humans, but are acquired through dietary 
intake. Other antioxidants are produced by the cells, where glutathione (GSH) is probably the 
most important (further discussed in section 1.3.2.1). These non-enzymatic antioxidants are 
depleted or modified and must be replenished or restored after their interaction with ROS. 
1.2.5 Selenium 
Selenium is an essential trace element, present in group IV of the periodic table. As selenium 
and sulfur are present in the same group they share many chemical properties. In humans, 
selenium can have both antioxidant and prooxidant properties, dependent on the chemical 
species and the concentration. Selenium is absorbed from the diet, both in organic and 
inorganic forms. After absorption, selenium is transported via the blood to the liver which is 
supporting the rest of the body with selenium, mainly by the production and secretion of 
selenoprotein P [37]. Selenoprotein P, the major source of selenium in plasma, is further 
taken up into other organs by receptor mediated mechanisms [38].  
Selenium is present in the 21st amino acid selenocysteine, and is crucial for the activity of 
several selenoproteins. Selenocysteine is incorporated into proteins through a unique and 
evolutionary conserved mechanism. The amino acid is encoded by the stop codon UGA and 
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incorporation of the amino acid requires a Selenocysteine Insertion Sequence (SECIS) 
element in the untranslated mRNA region [39]. Recruitment of a specific elongation factor by 
SECIS binding protein (SBP2) translates UGA as selenocysteine instead of termination [40]. 
Furthermore, selenocysteine is, in contrast to the other amino acids, synthesized on its 
specific tRNA (incorporation of selenium has been reviewed in [41]). So far, 25 human 
selenoproteins have been described, many of them are redox active (e.g. thioredoxin 
reductases and glutathione peroxidases), however the function of many selenoproteins are yet 
to be determined.  
Selenium may be either an antioxidant or an oxidant. The function is strictly concentration 
dependent, where too low levels will lead to reduced levels of important selenoproteins, while 
a too high concentration leads to severe toxicity. Selenium deficiency has been shown to be 
implicated in numerous pathologies, for example cancer [42], cardio-vascular disease [43], 
and immunodeficiency [44]. In a recent study of selenium deficient elderly people a 
significantly increased risk of cardiovascular mortality (56%) was observed in persons with 
serum selenium in the lowest quartile compared to the quartile with the highest selenium 
level [45]. A previous study showed a significant reduction in cardiovascular mortality as a 
result of supplementation with selenium and coenzyme Q10 [46]. In contrast, high selenium 
intake may cause selenosis which might be lethal [47, 48].  
1.2.6 Imbalance in the oxidative/antioxidative systems 
An imbalance between prooxidants and antioxidants is causing an oxidative stress in cells. 
The reactive species that are not scavenged by antioxidants can cause oxidative damage to 
proteins, membranes, and DNA [49]. The impact on the organism depends on the type of 
ROS, the activity of the antioxidant systems, and the efficiency of the repair systems.  
1.2.7 Oxidative modifications of protein thiols 
Oxidative modifications to proteins can in some cases be beneficial, and occur in a controlled 
manner. For example in the ER, which has a highly oxidizing internal milieu, protein 
disulfide isomerase (PDI) is responsible for the folding of proteins and uses oxidation to 
shape them to their correct tertiary structure [50].  
Oxidative modifications can also occur in a non-controlled manner where the cysteine 
residues play a vital role. The cysteine thiol is highly reactive, and is therefore sensitive to 
oxidation insults [29]. The thiol (-SH) moiety in the side chain of the amino acid cysteine is a 
nucleophilic functional group that is highly susceptible to oxidation, particularly by ROS. 
Oxidation of the -SH group in the side chain of cysteine can result in the formation of 
intramolecular and intermolecular disulfide bridges and the formation of sulfenic acid (S–
OH), sulfinic acid (SO2H), and sulfonic acid (SO3H), all of which can alter the function or 
activity of proteins [51]. In addition, sulfenic acid is highly prone to glutathionylation (further 
discussed in 1.3.2.2) (Figure 2). These changes has for long been considered as negative, as 
many proteins become inactive due to the oxidative insult, but in recent years the role of 
oxidative modifications as redox switches has come into focus.  
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Figure 2. Oxidative modifications of cysteine residues in proteins. 
  
1.2.8 Redox switches 
Thiols can be readily modified in response to increased oxidative stress. A redox signal, such 
as hydrogen peroxide, can lead to a reversible redox alteration to thiols in a target protein. 
Once the initial redox signal has returned to basal levels, the alteration reverses, and the 
activity of the protein reverts to its initial level. This general scenario for redox signaling by 
thiol proteins has been found in a number of cytosolic signaling systems [52]. For example, 
several transcriptions factors are regulated by oxidation/reduction of cysteine residues (e.g. 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) and nuclear factor 
erythroid 2-related factor 2 (Nrf2)/ Kelch like ECH-associated protein 1 (Keap1)) [53].  
1.3 THIOREDOXIN SUPERFAMILY OF PROTEINS 
The thioredoxin superfamily of proteins is a group of proteins with the main function to 
reduce disulfides formed by oxidation of cysteines. Several of the proteins share the same 
tertiary structure, named the thioredoxin fold, consisting of four β-sheets surrounded by three 
α-helixes [54]. The super family comprises the thioredoxin (Trx) and the glutaredoxin (Grx) 
systems, but also other groups of proteins, e.g. the protein disulfide isomerase (PDI) family.  
1.3.1 Thioredoxin and thioredoxin reductase 
Thioredoxin is a small (~12 kDa), ubiquitously expressed protein with two redox active 
cystine residues (-Cys-X-X-Cys-) in its active center [55]. Trx was first characterized in E. 
coli in 1964 as the hydrogen donor in the enzymatic synthesis of deoxyribonucleotides [56]. 
Shortly after, thioredoxin reductase (TrxR) was identified as the reductant of Trx [57].  
The active thiol in Trx acts as a nucleophile to attack the target disulfide on the substrate, 
forming a disulfide bridge with the substrate, denoted a mixed thiol. The second cysteine 
residue in Trx, called the resolving thiol, is reducing the target proteins disulfide. The 
oxidized disulfide left in Trx will be recycled to its reduced state by TrxR, utilizing NADPH 
as the electron donor. Normal function of TrxR requires two subunits of TrxR arranged head-
to-tail. Due to this homodimeric subunit configuration the enzyme has two active sites, and 
both subunits are needed for one catalytic cycle [58] (Figure 3).  
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Figure 3. Trx/TrxR system.  (A). Reduction of an oxidized thiol on a protein. The active thiol 
on Trx binds to the target protein, forming a mixed thiol. The second thiol is further donating 
its thiol to the target protein leaving the target thiol reduced, at the expense of becoming 
oxidized itself. (B). Basic mechanism for reduction of Trx. Oxidized Trx is reduced by TrxR at 
the expense of NADPH and H+.   
 
There are two human isoforms of Trx, the cytosolic Trx1 which also has the ability to 
translocate to the nucleus or to be secreted extracellularly [59, 60], and the mitochondrial 
Trx2 [61]. In addition, a truncated form of Trx1, Trx80, has been found in plasma. Trx80 is 
redox inactive, and is mainly produced by activated monocytes [62]. The biological function 
of Trx80 in plasma is not known, but it has been found to act as a cytokine [63, 64]. In 
addition to reduction of protein thiols, Trx has the ability to reduce Prx, and is for that reason 
indirectly involved in the scavenging of H2O2 [65]. 
Thioredoxin reductase (TrxR) is a selenoprotein with selenocysteine in its active site, and 
replacement of selenocysteine with a cysteine resulted in drastically decreased enzymatic 
activity [66]. TrxR is expressed in the cytosol (TrxR1) and in mitochondria (TrxR2), 
furthermore there is a testis specific TrxR3 [58]. Low level of TrxR has also been found in 
human plasma [67], and the level in plasma was increased in a mouse model treated with 
hepatotoxic compounds [68]. TrxR is the only enzyme known that can reduce Trx and is 
therefore an essential part of the thioredoxin system [69]. The main substrate for TrxR is Trx, 
but the list of substrates has grown long, and now includes e.g. selenium compounds [70, 71], 
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lipid hydroperoxides [72], ubiquinone [66], lipoic acid [73], and ascorbate [74]. Furthermore, 
TrxR has the ability to directly reduce disulfides in proteins using NADPH as its primary 
electron donor. 
The expression of several antioxidant genes is regulated by the transcription factor Nrf2. Nrf2 
binds to the DNA promotor region denoted the antioxidant response element (ARE) [75]. 
Nrf2 itself is a short lived protein and is rapidly subjected to proteasomal degradation, by 
either of its three negative regulators; Keap1, glycogen synthase kinase (GSK)3/β, or E3 
ubiquitin ligase Hrd1. Cysteine modifications to Keap1 blocks its ability to bind to Nrf2, 
which hinders degradation of Nrf2 and allows it to translocate to the mitochondria and bind to 
ARE where transcription will be initiated [53]. Trx and TrxR are both expressed under ARE 
and are therefore, in addition to other transcriptions factors, regulated by Nrf2 [69]. 
1.3.2 Glutaredoxin 
Glutaredoxin (Grx) has similar functions as Trx, with the main function to reduce disulfides. 
The glutaredoxins has three characteristic regions: the dithiol/disulfide active site, CSYC, the 
GSH binding site, and a hydrophobic surface area. There are two classes of Grx, divided 
according to their active site motifs. The first class has many similarities to Trx, with the 
active site Cys-X-X-Cys, and the second class has a monothiol active site [76, 77]. Due to the 
differences in the active site the Grx’s has two different ways of exerting their function, a 
monothiol or a dithiol mechanism [78] (Figure 4). The glutaredoxins are kept in their reduced 
form by GSH which in turn utilizes NADPH dependent glutathione reductase (GR) for 
reduction.  
 
Figure 4. The Grx system and the deglutathionylation process. The dithiol mechanism is 
described in the top part, and the monothiol/deglutathionylation mechanism below.  
 
There are four human Grx isoforms; Grx1 is cytosolic, Grx2 is expressed in three splice 
variants; mitochondrial Grx2a, nuclear Grx2b, and cytosolic Grx2c, Grx3 is expressed in the 
cytosol, and Grx5 is mitochondrial.  
Grx1 is primarily a cytosolic protein, but it has been found to translocate into the nucleus 
where it regulates several transcription factors [79]. Human Grx2 was first described as a 
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mitochondrial protein [80], but in a second article published almost at the same time, Grx2 
was found to have alternative splicing variants and a nuclear translocation signal [81]. Grx2 is 
an iron sulfur cluster (Fe/S) protein which in its inactive form is comprised by two Grx2 
molecules and [2Fe-2S]. The Fe/S is released during oxidative stress and Grx2 becomes 
active [82]. Grx1 and Grx2 are dithiols and the mechanisms for reduction of a substrate are 
similar to the reaction for Trx1. Furthermore, both Grx1 and Grx2 has also been found to be 
secreted into plasma [83]. Grx2 catalyzes the reduction of glutathionylated substrates with a 
lower rate but higher affinity compared to Grx1, with a particular high efficiency for 
glutathionylated substrates including GSSG. In addition, it has been shown that Grx2a can be 
reduced by TrxR2 [84]. Grx3 (also known as PICOT) is also a Fe/S protein and has, in 
contrast to Grx1 and Grx2, only one thiol in its active center [85]. The less studied Grx5 is 
also a monothiol and has been shown to be important in the synthesis of Fe/S clusters within 
the mitochondria [86].  
1.3.2.1 Glutathione and glutathione reductase 
GSH is a tripeptide (γ-glutamyl-cysteinyl-glycine) synthesized in almost all eukaryotic cells, 
with a concentration of 0.5-10 mM in most cells [87, 88]. The major function of GSH is to 
serve as thiol redox buffer, thereby maintaining the redox balance and protect against 
oxidative stress [89, 90]. However, studies on GSH depleted cells showed that, unlike 
thioredoxin, GSH could not support by itself the redox duties of the cell [91]. 
The synthesis of GSH from glutamate, cysteine, and glycine is catalyzed by two cytosolic 
enzymes, glutamylcysteine synthetase (GCS) and GSH synthetase. The production of GSH 
occurs in virtually all cell types, with the liver being the major producer and exporter [87]. 
The oxidized form of GSH is GSSG which is reduced by glutathione reductase (GR) at the 
expense of NADPH. Maintenance of optimal GSH/GSSG ratio in the cell is of importance for 
normal cell function and survival. In addition to several proteins in the Trx family of proteins, 
ARE regulates the cystine/glutamate antiporter (xCT) via Nrf2 which is essential for GSH 
synthesis.  
1.3.2.2 Glutathionylation 
There are many different types of reversible protein modifications, e.g. phosphorylation, 
acetylation, ubiquitination, and glutathionylation. Glutathionylation is a process where 
glutathione is bound to proteins as a way of either temporarily inhibiting their activity or as a 
way to protect them against irreversible oxidation [92]. Glutathionylation can, in contrast to 
e.g. phosphorylation which is enzymatically regulated, occur spontaneously, and any protein 
could be attacked by GSH if the protein sulfhydryl is in the form of sulfenic acid. However, 
the typical redox potential of protein-Cys moieties prevents formation of protein-SSG via 
thiol-disulfide exchange with GSSG unless the GSSG concentration is unusually high. 
Furthermore, in order for most Cys residues to be glutathionylated, there must first be an 
activated intermediate formed, such as sulfenic acid [92]. Glutathionylation may be a 
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mechanism to regulate the level of glutathionylated proteins in the cell, however in most 
studies glutathionylation has been found to occur during oxidative stress [93].  
Grx can catalyze the deglutathionylation of glutathionylated proteins [94], and catalyzes the 
deglutathionylation of protein-GSH mixed disulfides far more efficiently than Trx or PDI 
[95]. The enzymatic mechanism of deglutathionylation with Grx involves two steps. First, 
one cysteine on Grx deglutathionylates protein-SSG via a thiol disulfide exchange reaction 
yielding protein-SH and a Grx-SSG intermediate. Secondly, Grx-SSG binds GSH and the 
glutathionyl moiety is removed, regenerating Grx1 and producing GSSG [96]. Protection of 
proteins by glutathionylation was shown in a study where cardiac mitochondria was exposed 
to hydrogen peroxide and α-ketoglutarate dehydrogenase was shown to be reversibly 
glutathionylated [97]. 
1.4 CELL AND TISSUE DAMAGE 
Oxidative stress has been implicated in several pathologies. For example, increased oxidative 
stress has been observed in several types of cancer, where ROS has been associated with 
cancer development, metastasis, cancer progression and survival [98]. Atherosclerotic 
diseases such as coronary artery disease (CAD) and stroke has been associated to oxidative 
stress, where fruits and vegetables high in antioxidants has emerged as an alternative 
treatment strategy [99]. In addition, increased oxidative stress index was observed in patients 
suffering from ischemic stroke [100] and oxidative damage to DNA is one of the earliest 
detectable events in neurodegenerative diseases [101]. 
1.4.1 Neurodegeneration 
Neurons possess properties that make them particularly vulnerable to oxidative stress, due to 
high energy and oxygen consumption and a membrane composed of high levels of 
unsaturated lipids. In addition, neurons contain high amounts of transition metals and their 
antioxidant defense is low compared to other types of cells [102]. Furthermore, the ATP 
turnover rate in the human brain is extremely high (4.7 × 109 ATPs/neuron/s), which means 
that a resting human brain utilizes approximately 5.7 kg ATP per day [103].  With this high 
oxygen turnover, even a small leakage of electrons from the ETC can lead to large changes in 
the redox balance.  
1.4.2 Alzheimer’s disease 
Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by 
impaired cognition and dementia. The major risk factor for AD is aging [104], but oxidative 
stress has been implicated in the pathogenesis. It is however debated whether oxidative stress 
is a cause or a consequence of the disease. AD is characterized by an irreversible loss of 
functional neurons primarily in the associative neocortex and hippocampus [105]. There are 
two major neuropathological signs for AD; extracellular accumulation of plaques 
(accumulation of β-amyloid (Aβ)), and the presence of intracellular neurofibrillary tangles 
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(aggregates of tau) [106]. The disease usually has a slow progression and major changes are 
likely to occur before any symptoms appear.  
1.4.2.1 Tangles formed by hyperphosphorylated tau 
In 1986, the paired helical filaments seen in AD brains were identified as the microtubule 
associated protein tau, a normal brain cytoskeletal protein which is stabilizing the axonal 
microtubule of the neuronal cells [107]. In AD, a phosphorylation of the protein occurs, 
causing the protein to aggregate and form intracellular tangles. Some degree of 
phosphorylated tau has been observed in patients without any clinical symptoms, suggesting 
that accumulation of the protein is an early event in the disease progression. An accumulation 
of phosphorylated tau impairs the neurons and decreases their functionality [108].  
1.4.2.2 Amyloid precursor protein and β-Amyloid 
Amyloid precursor protein (APP) is a protein expressed in the adult human brain. Increased 
expression of APP can be seen during neuronal differentiation and neurite outgrowth, 
suggesting a role for APP in the development of the nervous system (the functions of APP 
has been reviewed in [109]).  
APP can be cleaved either by α-secretase or β-secretase [110], generating a secreted N-
terminal soluble fragment (sAPPα or sAPPβ) and a C-terminal APP fragment (α-CTF or β-
CTF). The CTF is further processed by γ-secretases whereby amyloid β (Aβ) peptides of 
various lengths are formed [111]. As α-secretase cuts APP within the Aβ region, Aβ 
generation is prohibited. However, cleavage of β-CTF leads to formation of Aβ peptides 
which can aggregate and form plaques (mainly Aβ1-42). Furthermore, Aβ1-42 has the ability to 
form oligomers that are soluble and highly neurotoxic, the basis for their potent toxicity is 
however not known [112]. Both Aβ oligomers and Aβ plaques are potent synaptotoxins that 
block proteasome function, inhibit mitochondrial activity, alter intracellular Ca2+ levels, and 
stimulate inflammatory processes [106]. All of these processes can further increase the 
formation of radicals, enhancing the oxidative stress in the affected neurons. Increasing 
evidence suggests that Aβ oligomers may be the primary cause of AD as they have a greater 
correlation with dementia than insoluble Aβ1-42 [113].  
1.4.2.3 Oxidative stress in AD pathology 
In addition, analysis of Aβ plaques from human brains revealed accumulation of aluminum, 
iron, copper and zinc in the plaque [114, 115]. Furthermore, the levels of the iron-
homeostatic peptide hepcidin, and the iron exporter ferroportin, were found to be reduced in 
hippocampal lysates from AD brains [116]. Aβ becomes a prooxidant when complexed to 
copper or iron generating hydrogen peroxide through the Fenton reaction. Due to the 
association of oxidative stress to AD, several studies with antioxidant treatment have been 
performed [117-120]. In these studies, the antioxidant vitamin E stands out as a promising 
treatment strategy in preventing memory loss in AD. It is however unclear whether the 
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positive effects seen early in the disease process will remain over longer periods of time or in 
more advanced stages of the disease. 
1.4.3 Parkinson’s disease 
Parkinson’s disease (PD) is characterized by a loss of the dopamine producing neurons 
primarily in the substantia nigra (SN) region of the human brain. The loss of these neurons 
leads to motor problems and manifests as involuntarily movements. The exact cause of the 
loss is still to be discovered, but oxidative stress has been implicated in the pathology [121], 
as shown by e.g. increased activity of SOD [122] and basal lipid peroxidation [123] in SN of 
PD patients. The major neuropathological sign of PD is inclusion bodies (Lewy bodies) 
which are constructed of α-synuclein [124, 125].  
1.4.3.1 The role of oxidative stress in Parkinson’s disease 
Decreased levels of reduced GSH have been observed in the SN region of PD patients, the 
levels of GSSG did however not differ between PD and controls, suggesting an increased 
oxidative stress in the tissue [126, 127]. In contrast, increased levels of GSH and 
antioxidative enzymes were observed in the frontal cortex of PD patients compared to 
controls [128], which means that the major impact of oxidative stress probably occurs in the 
areas that are mainly affected in PD. Increased levels of iron has been observed in SN of PD 
patients, and no difference could be observed in the cerebellum [129]. Furthermore, 
decreased levels of selenium have been observed in patients with PD [130]. The redox 
imbalance in the affected neurons causes oxidative damage to the neurons and begins to alter 
the synthesis and metabolic pathway of dopamine, which leads to further increase in 
oxidative stress.    
1.4.3.2 Dopamine 
Dopamine is a signaling molecule in the motor neurons and is normally stored in vesicles 
intracellularly in the neurons and is released upon stimuli. In the presence of oxidative stress 
and α-synuclein the storage is disrupted leading to an increased dopamine concentration in 
the cytoplasm [124]. Once in the cytoplasm, dopamine will react with molecular oxygen 
forming 3,4-Dihydroxyphenylacetic acid (DOPAC) or Dopamine semi-quinone. The 
oxidation to DOPAC requires the enzyme monoamine oxidase (MAO) [131]. During the 
oxidation processes, hydrogen peroxide or superoxide is released [121]. (Figure 5)  
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Figure 5. Dopamine and its metabolites.  
 
1.4.4 Ischemia/Reperfusion 
Ischemia is a phenomenon that occurs when the cells do not receive the amount of oxygen 
required for their normal metabolism due to restriction of blood flow, caused by e.g. stroke, 
heart infarction, or surgical procedures. When the blood flow returns, and oxygen reenters the 
tissue, reperfusion injury can occur. The major impact of reperfusion injury is attributed to 
oxidative stress. Increased production of radicals during reperfusion has been linked to 
xanthine oxidase, mitochondria, NADPH oxidase, and uncoupled nitric oxide synthase [132].   
Hypoxanthine and xanthine are metabolites formed during ATP utilization. During normal 
oxygen levels, hypoxanthine is metabolized by xanthine dehydrogenase (XDH) to xanthine 
and ultimately to uric acid at the expense of NAD+. During ischemia ATP is utilized, but 
cannot be resynthesized, and as a result of the mitochondrial oxidative phosphorylation its 
metabolites adenosine, inosine, hypoxanthine and xanthine accumulate. In addition, the levels 
of Ca2+ increases in the cytoplasm due to failure of the ATP dependent Ca2+ pumps. With the 
onset of ischemia, the rise in intracellular calcium results in a proteolytic conversion of XDH 
to xanthine oxidase (XO), which uses molecular oxygen instead of NAD as its electron 
acceptor. When the restriction of blood flow is removed, with a massive influx of oxygen into 
the tissue, XO will catalyze the production superoxide [133, 134] (Figure 6). 
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Figure 6. Conversion of XDH to XO during IR.  
 
In addition to the production of ROS, reduced levels of antioxidants has been connected to 
injuries from IR, as the GSSG/GSH ratio increases when the liver is subjected to ischemia 
[135]. Furthermore, activation of the transcription factor Nrf-2 has been reported in studies of 
oxidative stress in relation to IR [136, 137]. 
Even though oxidative stress is usually considered as something negative, low levels of 
oxidative stress can be beneficial to the cells as the antioxidant systems are upregulated, 
preparing the cell for increased oxidation [138].  
1.4.5 Effect of microenvironment 
The microenvironment is of great importance in all systems including cell culturing. Minor 
changes in the microenvironment can lead to substantial changes in the response to toxic 
compounds.  For example, dependent of the medium selected, the compound used may be 
oxidized in the culturing medium, leading to treatment by a different compound than intended 
[2]. The expression of membrane transporters may also affect the outcome of cellular 
experiments. The amount of extracellular thiols and the ability to sustain high levels of 
especially cysteine is one factor shown to determine the tumor specificity of selenium 
compounds [139]. Furthermore, the glucose level in the culturing medium was shown to 
induce epithelial to mesenchymal transition (EMT) in a recent publication using a breast 
cancer cell line [140]. Another recent study showed that high glucose induced EMT was 
caused by increased intracellular ROS production, and inhibition of Trx activity, which was 
prevented either by treatment with the antioxidant NAC or inhibition of thioredoxin 
interacting protein [141]. 
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2 THE PRESENT INVESTIGATION 
2.1 AIMS OF THE STUDY 
Thioredoxin and glutaredoxin are important for protection against damage sustained by 
oxidative stress. This study aimed at evaluating the role of redox proteins in cell and tissue 
damage.  
2.2 RESULTS AND DISCUSSION 
2.2.1 Paper I 
Alteration of Thioredoxin and Glutaredoxin in the Progression of Alzheimer's Disease 
2.2.1.1 Background 
Oxidative stress has been implicated in AD, and the Trx family of proteins plays an important 
role in protecting the cells against oxidative stress. Previous studies on the involvement of 
Trx and Grx in AD has been conflicting, and few human studies have been performed with 
respect to the redox proteins. In this study we were examining the role of Trx and Grx in AD. 
The levels in hippocampus in advanced stages of AD as well as the levels of the proteins in 
plasma and cerebrospinal fluid (CSF) from patients with different stage of AD were 
evaluated. Furthermore, before onset of clinical symptoms, AD is often mistaken for 
depression, and it is difficult to make a distinction between the two. A reliable panel of 
biomarkers would greatly improve in the diagnosis of the disease and help in determining 
which treatment strategy to pursuit.  
2.2.1.2 Aim 
The aim of the study was to evaluate the role of Trx and Grx at different stages of AD.  
2.2.1.3 Methods and results 
Sandwich enzyme linked immuno sorbent assay (ELISA) was used to study the levels of 
Trx1 and Grx1 in patients with different stages of AD. Patients with depression were used as 
a control group, as the early stages of the AD often resemble depression. Both Trx1 and Grx1 
was shown to be released into CSF, furthermore the levels was shown to increase in early 
stages of the disease compared to mild cognitive impairment. As the levels of lactate 
dehydrogenase did not differ between the stages, we conclude that Trx and Grx are secreted 
rather than increased due to cell death. Trx and Grx levels were shown to correlate well with 
the levels of previously established biomarkers Tau and P-tau. When combining all the used 
diagnostic markers (MMSE-score, Tau and P-tau) with Trx and Grx levels we were able to 
distinguish between the different stages of the disease in 32 out of 33 patients. Trx was shown 
to be particularly valuable in the distinction between MCI sable and MCI converter.  
Immunohistochemistry (IHC) was used to evaluate the expression of Trx and Grx isoforms in 
postmortem hippocampus sections of advanced stages of AD. Axonal staining for both Grx1 
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and Grx2 was observed in the control sections but not in the AD hippocampus. A nuclear 
localization of Trx1 was observed in the control sections while the staining was mainly 
cytosolic in the AD samples. Decreased intensity of mitochondrial staining for Trx2 was 
observed in AD compared to control. 
2.2.1.4 Conclusion 
Oxidative stress has been linked to early changes in AD. Including Trx in in the biomarker 
panel for AD could improve in the diagnosis, and especially improve in the distinction 
between mild cognitive impairment and early AD. Furthermore, a secretion of Grx and Trx 
into the CSF and plasma implicates that the proteins are important extracellularly for 
protection against ROS formation. Further studies are needed in order to fully understand the 
role of the redox proteins in AD. 
2.2.2 Paper II 
Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell 
death 
2.2.2.1 Background 
The exact cause of Parkinson disease is still unknown, but oxidative stress has been 
connected to early events in the disease progression. Increased oxidative stress in the 
dopaminergic cells can lead to the disruption of the storage of dopamine which is highly 
sensitive to oxidation. When dopamine is released in the cytosol, it will readily react with 
oxygen and form the toxic dopamine quinone. During this process, radicals will also be 
released. Since the Trx system is involved in protection against oxidative stress, the system is 
likely to be implicated in PD. 
2.2.2.2 Aim 
The aim of this study was to investigate the role of Trx and Grx in the defense against 
dopamine induced cell death.  
2.2.2.3 Methods and results 
IHC was used to determine the expression of Trx and Grx in substantia nigra of PD patients. 
Significant downregulation of Trx1 and TrxR1 were observed in PD patients compared to 
control. 
The neuroblastoma cell line SH-SY5Y and the nematode C. elegans were used as model 
systems, and treatment with the dopamine metabolite 6-hydroxydopamine (6-OHDA) was 
performed. Pretreatment with low levels of selenite protected SH-SY5Y cells against 6-
OHDA toxicity. No difference in mRNA level of the redox proteins could be observed by the 
pretreatment with selenite, but 6-OHDA treatment alone increased the mRNA levels of Trx1, 
TrxR1, TrxR2, Grx1 and Grx2. No change in the protein levels of Trx and Grx could be 
detected upon 6-OHDA treatment, the activity of TrxR was however shown to be increased 
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as determined by enzymatic assays. Furthermore, the toxicity of 6-OHDA was determined 
after knocking down the redox proteins with small interfering RNA, increased toxicity could 
be observed after a knock down of TrxR1, Grx1 and Grx2, but not in Trx1 siRNA. 
Knockdown experiments of trxr-1 and trx-5 in the nematode c. elegans were performed, and 
increased neuronal degradation could be observed in worms lacking TrxR1 upon treatment 
with 6-OHDA.    
In addition, an enzymatic assay to determine if 6-OHDA could interact with the Trx and Grx 
systems was performed. We could demonstrate that TrxR had the capacity to reduce the 6-
OHDA-quinone and that the reaction efficiency was increased in the presence of Trx. Even 
though not as efficient, GSH was shown to reduce the quinone, and the reaction rate 
increased in the presence of Grx.  
2.2.2.4 Conclusion 
This study demonstrate that the Trx and Grx system not only play an important role in 
dopamine induced cell death, but also exert critical protective effects by direct enzymatic 
reduction of the neurotoxic dopamine metabolite 6-OHDA-qouinone.  
2.2.3 Paper III 
Morphological alterations and redox changes due to ischemia-reperfusion injury during 
liver surgery 
2.2.3.1 Background 
Ischemia/reperfusion (IR) injury is a known cause for complications during liver resection 
and surgery, caused by oxygen deprivation followed by a burst of oxygen into the tissue. The 
deprivation of oxygen is leading to ATP depletion which causes an increase in the 
cytoplasmic Ca2+ levels which results in conversion of XDH to XO. When hypoxanthine is 
metabolized by XO superoxide will be produced as a side product. The increased oxidative 
stress in the cells during reperfusion is causing damage to the tissue. Only few studies have 
investigated the cellular and ultrastructural changes on human tissue due to IR.  
2.2.3.2 Aim 
The aim of this study was to evaluate the cellular and ultrastructural changes due to IR in 
human liver tissue. In addition, the impact on the Trx and Grx system was evaluated.  
2.2.3.3 Methods and results 
In this study liver surgery was used to model IR in a human tissue. During routine surgery of 
11 patients, ischemia was induced by portal triad clamping (PTC), also known as the Pringle 
maneuver, which has been one of the most widely used methods to reduce blood loss during 
hepatic surgery. Liver samples were collected at three time points; before induction of 
ischemia, 20 minutes post-ischemia, and 20 minutes post-reperfusion. Electron microscopy 
(EM) was used to study the ultrastructure of the liver tissue. Post-ischemia a disruption of the 
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sinusoidal lining of the liver cells was observed in 10 out of the 11 patients. Post-reperfusion, 
the sinusoidal lining reappeared and a reactivation of the sinusoidal cells could be observed. 
In addition, paracrystalline inclusions could be observed in the mitochondria in seven of the 
11 patients post-ischemia. These inclusions were still present post-reperfusion.  
In order to study the involvement of redox proteins in IR, mRNA levels of the redox proteins 
were determined by qPCR, but no changes were detected. Immuno-gold electron microscopy 
was used to study Trx1 and Grx1 in situ. Even though there were no significant inter-
individual differences in detected Trx1 levels, the intra-individual Trx1 levels differed 
between baseline, post-ischemia, and post-reperfusion.  
2.2.3.4 Conclusion 
This study was undertaken to evaluate the effect on liver morphology and expression of redox 
proteins during IR. We could show that the major burden of IR is borne by the endothelial 
cells lining the sinusoids in the liver, and the hepatocytes remained almost unaffected, 
deeming PTC a safe method to use in liver surgery. As Trx1 seems to change in localization 
we suggest a possible role for especially Trx in the protection against IR induced damage. 
Further studies are needed in order to fully understand the role of redox proteins in IR. 
2.2.4 Paper IV 
The effect of media composition on cell growth, thiol status, redox proteins, and in 
selenium toxicity 
2.2.4.1 Background 
Cell lines are extensively used in medical research, as they provide a cost effective and 
flexible experimental model. However, general guidelines of how to maintain a specific cell 
line with regard to culturing media are lacking. The composition of culturing media differs in 
terms of components and concentration, and the same media purchased from different 
suppliers may not have the same constituents. 
2.2.4.2 Aim 
The aim of this study was to evaluate whether different culturing conditions could influence 
the proliferation, morphology, differentiation, thiol levels, expression of redox proteins, and 
sensitivity to selenium toxicity.   
2.2.4.3 Methods and results 
The three cell lines used in this study (A549, Huh7, and HepG2) were cultured in four 
commonly used media (RPMI, DMEM, MEM, and F12). DMEM was shown to increase the 
proliferation rate in the cells, and culturing cells in MEM resulted in the lowest proliferation 
rate. Furthermore, cells were cultured on glass slides and stained for the epithelial marker 
cytokeratin (CK18) and the mesenchymal marker Vimentin. A549 cells had a low expression 
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of CK18 when cultured in MEM and DMEM, and the expression of Vimentin increased 
when cultured in DMEM. 
The extracellular concentration of thiols was determined by enzymatic assay and was shown 
to be increased in Huh7 cells cultured in F12 compared to RPMI. The expression of the redox 
proteins Trx1, Grx1 and TrxR1 was studied using ELISA or western blot. No changes were 
observed in cells cultured in the different media. In contrast, increased activity of TrxR could 
be observed in A549 cells cultured in MEM compared to the other media.  
To study the response to toxicity, the two selenium compounds, selenite and seleno-
methylselenocysteine (MSC) were used and viability determined 48 hours after addition of 
the compound. The toxicity of selenite was shown to be decreased in A549 cells cultured in 
DMEM compared to culture in RPMI or F12.   
2.2.4.4 Conclusion 
The selection of culture medium is of outermost importance as changes in morphology, 
response to toxicity and activity of redox protein may differ widely depending on the 
particular medium selected. These results highlight that the culturing conditions are crucial, 
as changes in the micro environment may profoundly change the outcome of the study.  
2.3 COMMENTS ON THE METHODOLOGIES 
2.3.1 Evaluation and image analysis of immunohistochemical staining 
Immunohistochemical staining is often used in order to show the localization and distribution 
of a particular protein. It is however difficult to correctly determine the level of staining. In 
order to make an unbiased evaluation of the level of staining image analysis software can be 
used. These programs are measuring the intensity or saturation of the staining. Technical 
pitfalls do however exist: 
(1) In immunological staining, the final step is usually performed by enzyme based color 
development. This step is crucial as the reaction is stopped either at a specific time or when 
the optimal amount of color has appeared. Both ways are easily causing lack in consistency, 
especially if the staining is performed at different time points.  
(2) Depending on the microscope and camera used, background color may differ, generating 
inconsistency in saturation levels.  
2.3.2 The importance of the model system employed 
Due to ethical considerations the possibilities to perform human studies are limited. 
Therefore, in order to study different aspects of disease, several model systems have been 
developed. Cell culture is usually used as a first set of tests. Cell lines are however far from a 
complex organism, and in order to fully understand the mechanism cell lines are usually not 
sufficient as an experimental model. When the researcher fails to acknowledge this, 
conclusions may be drawn that do not reflect the truth.  
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3 GENERAL DISCUSSION AND FUTURE PERSPECTIVES 
Oxidative stress has been implicated as a major pathogenic mechanism in several diseases. 
The focus of this study was to investigate the role of the two redox proteins Trx and Grx in 
different pathological conditions.   
The cause of most neurodegenerative diseases is still to be discovered. One likely contributor 
is oxidative stress which has been found to be elevated in both AD and PD. In Paper I the 
expression profiles of Trx and Grx were established in cerebrospinal fluid (CSF) and plasma 
at different stages of AD. We were able to show that the level of Trx in CSF differed in AD 
during disease progression. The level of especially Trx1 showed high correlation to the 
previously established and validated biomarkers tau and p-tau. There is a need for sensitive 
and specific markers in order to diagnose the disease also at an early stage and monitor the 
disease progression. In addition, we for the first time showed that Grx1 is released to the 
CSF. The levels of Trx1 and Grx1 in CSF did not correlate with the levels of lactate 
dehydrogenase, indicating that the proteins were secreted rather than released due to cell 
death. This finding suggests that Trx and Grx may play a role extracellularly in AD 
pathology. Further studies are however needed in order to elucidate their importance in the 
CSF. Furthermore, axonal staining for Grx1 and Grx2 was observed in the control brains, but 
not in the AD brains. A decreased mitochondrial staining for Trx2 was found in AD. 
However, this observation should be interpreted with caution due to the methodological 
limitations as a quantitative method. 
Increased oxidative stress has been implicated in PD, which can lead to the disruption of 
dopamine storage. Dopamine is highly prone to oxidation and free radicals are released 
during the oxidation process. In Paper II the role of the Trx family of proteins in dopamine 
induced cell death was evaluated. We showed that Trx and TrxR could directly reduce the 
quinone of dopamine. In addition, in PD brains, decreased levels of both Trx1 and TrxR1 
were detected. The effect of dopamine induced cell death was further evaluated in different 
model systems, the cell line SH-SY5Y and the nematode C. elegans. An increased toxicity of 
dopamine was observed in cells with reduced levels of TrxR1 or Grx1 (by siRNA), and 
increased neuronal degradation was observed in nematodes lacking expression of TrxR1. In 
conclusion, the Grx and particularly the Trx system play an important role in protecting 
neurons against dopamine induced cell death.   
In IR, the major impact on the tissue is believed to occur during reperfusion, when for 
example the conversion of hypoxanthine to xanthine is producing radicals as a side product. 
In Paper III, we showed that the major changes in the liver occurred in sinusoidal 
endothelial cells and that changes observed after 20 minutes of ischemia were reversible and 
had partially reverted after 20 minutes of reperfusion. Furthermore, the role of Trx and Grx in 
ischemia and reperfusion was investigated. The mRNA levels of the proteins did not change 
during the study period. The lack of observed changes might be explained by the fact that the 
RNA was purified from whole lysate, and not from one specific cell type. We could not 
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detect any changes in protein levels of Grx1 and Trx1 in the hepatocytes when measured by 
immuno gold. However, in some patients lower levels of Trx were observed at reperfusion 
compared to the earlier time points. This effect might indicate a possible secretion of the 
protein and merits further investigation with a larger number of patients. In future studies, 
sampling of plasma would be important to confirm this hypothesis.  
Paper IV is a methodological study where we studied the effect of cell culture media 
composition on cell growth, thiol status, redox proteins, and in selenium toxicity in three 
different cell lines. Depending solely on the media used we observed significant changes in 
TrxR activity, a possible change in phenotype, and differences in toxic effects of selenium 
compounds. A significant factor that may contribute to this observed culture media effect is 
the great variation in glucose concentrations in the different culture media used.  
Our observed culture media effects rise serious concerns comparing experimental data from 
different cell culture studies when different media have been used and thus highlights the 
relevance and importance of this methodological study.  
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